Journal of Pediatric Hematology/Oncology | 2024
Why are higher cd34+ cell doses associated with improved outcomes among pediatric patients undergoing autologous hematopoietic stem cell transplant for central nervous system tumors - but not for high-risk neuroblastoma?
Knight TE, Broglie L, Sharma A, Qayed M, Yanik GA
PubMed
PMID: 39501613
Abstract
Related Articles
CIBMTR Study #: PC20-01